Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treating human autoimmune disease by depleting B cells.

Literature DB >> 12228152

Treating human autoimmune disease by depleting B cells.

R J Looney¹.

Abstract

Entities: Disease Species

Mesh：

Substances：

Year: 2002 PMID： 12228152 PMCID： PMC1753906 DOI： 10.1136/ard.61.10.863

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

× No keyword cloud information.

40 in total

1. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma.

Authors: D G Maloney; A J Grillo-López; C A White; D Bodkin; R J Schilder; J A Neidhart; N Janakiraman; K A Foon; T M Liles; B K Dallaire; K Wey; I Royston; T Davis; R Levy
Journal: Blood Date: 1997-09-15 Impact factor: 22.113

2. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice.

Authors: O Chan; M J Shlomchik
Journal: J Immunol Date: 1998-01-01 Impact factor: 5.422

3. B cell-deficient mice do not develop type II collagen-induced arthritis (CIA).

Authors: L Svensson; J Jirholt; R Holmdahl; L Jansson
Journal: Clin Exp Immunol Date: 1998-03 Impact factor: 4.330

4. T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes.

Authors: Y Ron; J Sprent
Journal: J Immunol Date: 1987-05-01 Impact factor: 5.422

5. Do B cells drive the diversification of immune responses?

Authors: M J Mamula; C A Janeway
Journal: Immunol Today Date: 1993-04

6. B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice.

Authors: H Noorchashm; N Noorchashm; J Kern; S Y Rostami; C F Barker; A Naji
Journal: Diabetes Date: 1997-06 Impact factor: 9.461

7. Synergy between encephalitogenic T cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encephalomyelitis.

Authors: K J Myers; J Sprent; J P Dougherty; Y Ron
Journal: J Neuroimmunol Date: 1992-11 Impact factor: 3.478

8. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20.

Authors: M E Reff; K Carner; K S Chambers; P C Chinn; J E Leonard; R Raab; R A Newman; N Hanna; D R Anderson
Journal: Blood Date: 1994-01-15 Impact factor: 22.113

9. The role of B cells in lpr/lpr-induced autoimmunity.

Authors: M J Shlomchik; M P Madaio; D Ni; M Trounstein; D Huszar
Journal: J Exp Med Date: 1994-10-01 Impact factor: 14.307

10. Induction of autoreactive B cells allows priming of autoreactive T cells.

Authors: R H Lin; M J Mamula; J A Hardin; C A Janeway
Journal: J Exp Med Date: 1991-06-01 Impact factor: 14.307

12 in total

1. Successful plasma exchange combined with rituximab therapy in aggressive APS-related cutaneous necrosis.

Authors: Rubens Costa; Salman Fazal; Robert B Kaplan; Joel Spero; Ricardo Costa
Journal: Clin Rheumatol Date: 2010-06-17 Impact factor: 2.980

2. Consensus statement on the use of rituximab in patients with rheumatoid arthritis.

Authors: J S Smolen; E C Keystone; P Emery; F C Breedveld; N Betteridge; G R Burmester; M Dougados; G Ferraccioli; U Jaeger; L Klareskog; T K Kvien; E Martin-Mola; K Pavelka
Journal: Ann Rheum Dis Date: 2006-10-26 Impact factor: 19.103

Review 3. Targeting B cells in treatment of autoimmunity.

Authors: S Elizabeth Franks; Andrew Getahun; P Mark Hogarth; John C Cambier
Journal: Curr Opin Immunol Date: 2016-10-05 Impact factor: 7.486

4. Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study.

Authors: P Stolt; H Källberg; I Lundberg; B Sjögren; L Klareskog; L Alfredsson
Journal: Ann Rheum Dis Date: 2004-08-19 Impact factor: 19.103

Review 5. Rituximab as a therapeutic tool in severe mixed cryoglobulinemia.

Authors: Dario Roccatello; Simone Baldovino; Daniela Rossi; Osvaldo Giachino; Morteza Mansouri; Carla Naretto; Debora Di Simone; Simona Francica; Roberto Cavallo; Mirella Alpa; Franca Napoli; Luigi M Sena
Journal: Clin Rev Allergy Immunol Date: 2008-02 Impact factor: 8.667